Interestingly, in a study conducted by Hsu et al., neither of the tested tubular damage markers (NGAL, KIM-1, or NAG) did not improve the C-statistic of the baseline clinical prediction model for CKD progression, which employed eGFR and urine albumin to creatinine ratio [73,74]. The gene discussed is HAVCR1; the disease is chronic kidney disease.